Provided by Tiger Trade Technology Pte. Ltd.

PagerDuty, Inc.

12.32
+0.20001.65%
Pre-market: 12.320.00000.00%04:00 EDT
Volume:2.20M
Turnover:26.96M
Market Cap:950.15M
PE:5.82
High:12.50
Open:12.10
Low:11.93
Close:12.12
52wk High:17.29
52wk Low:5.70
Shares:77.12M
Float Shares:69.58M
Volume Ratio:2.23
T/O Rate:3.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.12
EPS(LYR):1.87
ROE:94.62%
ROA:1.82%
PB:4.39
PE(LYR):6.59

Loading ...

PagerDuty shareholders elected four directors at annual meeting

Reuters
·
Jun 23

PagerDuty names Eric Prengel CFO as Howard Wilson retires

Reuters
·
Jun 23

PagerDuty Appoints Eric Prengel as Chief Financial Officer

THOMSON REUTERS
·
Jun 23

How Investors Are Reacting To Agilent Technologies (A) Expanding PD-L1 Test Use And Launching New AI Partnership

Simply Wall St.
·
Jun 16

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

GlobeNewswire
·
Jun 15

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

GlobeNewswire
·
Jun 14

SIMCERE PHARMA Receives NMPA Approval for Clinical Trial of SIM0689, a Dual-Target Antibody

Stock News
·
Jun 12

Simcere Wins NMPA Green Light for PD-1/VEGF Bispecific Cancer Therapy

TIPRANKS
·
Jun 12

PagerDuty survey finds 66% of office professionals use unauthorized AI tools at work

Reuters
·
Jun 11

Press Release: AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson's Disease

Dow Jones
·
Jun 11

Southwest Securities: Post-PD-(L)1 Treatment Resistance Poses Significant Challenge, 2026 to See High Concentration of Catalysts

Stock News
·
Jun 11

PagerDuty announces Ingram Micro as authorized distributor in Australia

TIPRANKS
·
Jun 09

PagerDuty names Ingram Micro exclusive distributor in Australia

Reuters
·
Jun 09

PagerDuty Expands Australia Footprint With Exclusive Distribution Agreement With Ingram Micro

THOMSON REUTERS
·
Jun 09

MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment

GlobeNewswire
·
Jun 08

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

GlobeNewswire
·
Jun 06

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

GlobeNewswire
·
Jun 05

PagerDuty price target raised to $10 from $7 at Morgan Stanley

TIPRANKS
·
Jun 03

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

GlobeNewswire
·
Jun 03

Agilent receives FDA approval for expanded use of PD-L1 IHC 22C3 pharmDx

TIPRANKS
·
Jun 03